Showing results (61-70 of 808) with videos related to
Sort By:
Pageof 81
Biological Psychiatry|December 15, 1994
1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlatesP F Buckley, C Moore, H Long, et al.Pharmacology, Biochemistry, and Behavior|September 23, 1997
Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonistsA M Deveney, J L WaddingtonEuropean Journal of Pharmacology|October 31, 1980
Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administrationJ L Waddington, S J GambleEuropean Journal of Pharmacology|May 8, 1981
Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatumA J Cross, J L WaddingtonPsychopharmacology|May 5, 1998
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approachJ J Clifford, J L WaddingtonNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2000
Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonistsJ J Clifford, J L WaddingtonNeuroscience Letters|September 1, 1979
Pharmacology of (+)- and (-)-baclofen: GABA-dependant rotational behaviour and [3H]GABA receptor binding studiesJ L Waddington, A L CrossNaunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 1979
Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor bindingJ L Waddington, A J CrossJournal of Psychopharmacology (Oxford, England)|February 1, 2012
D-1 dopamine receptors and the topography of unconditioned motor behaviour: studies with the selective, 'full efficacy' benzazepine D-1 agonist SKF 83189S A Daly, J L WaddingtonEuropean Journal of Pharmacology|September 4, 1990
The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indicesA M Murray, J L WaddingtonPageof 81